PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE
Clinical trials for PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE explained in plain language.
Never miss a new study
Get alerted when new PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE trials appear
Sign up with your email to follow new studies for PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for halting deadly lung scarring
Disease control OngoingThis study is testing whether a new drug called ENV-101 can help slow down lung scarring and improve breathing in adults with idiopathic pulmonary fibrosis (IPF), a serious lung disease. About 213 participants will receive either one of three doses of ENV-101 or a placebo for six…
Matched conditions: PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE
Phase: PHASE2 • Sponsor: Endeavor Biomedicines, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New scan seeks to spot lung damage earlier
Knowledge-focused OngoingThis study is testing a new, non-invasive MRI scan that uses a special gas (xenon) to see inside the lungs. Researchers want to see if this scan can detect early signs of lung scarring and heart changes better than current tests. The goal is to help doctors monitor disease progre…
Matched conditions: PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE
Sponsor: University of Aarhus • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:43 UTC